Two articles in the September 4 Chain Drug Review capture well the future-focused messaging and the unmatched business opportunities at the 2023 NACDS Total Store Expo. The event was held August 12-14 in San Diego, CA.
The NACDS Total Store Expo shined in sunny San Diego, CA, with a “total store, total person” approach to health and wellness.
The FTC on Thursday voted, 3-0, “to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit managers (PBM) that no longer reflect current market realities.”
Through the engagement of the membership, NACDS brought its pro-patient and pro-pharmacy perspective to the IRA during its Congressional consideration and continues to shape the IRA during its implementation.
“Specifically, we request FDA use its authority under the law for dispensers to comply with the EDDS requirements no earlier than February 27, 2026.”
FTC: “The statement is a response to PBMs' continued reliance on older FTC advocacy materials”
From industry trade press, to publications serving the broader business community, to media outlets relied on by government decision-makers, important story lines about pharmacy benefit manager reform continue to generate headlines and attention across the nation.
Utilize and share our “Unbreakable” TV/Digital Ad celebrating pharmacy’s dedication, Public Opinion Dashboard of attitudes on important topics, & Access Agenda’s pro-patient, pro-pharmacy policy priorities.
See Jeff Woldt’s May 22 article in Mass Market Retailers — “Time is right for NACDS to once again 'deliver’” — which describes well NACDS’ pro-patient, pro-pharmacy policy priorities.
The NACDS Foundation recently launched nearly $2 million in support of new research projects that seek to address gaps in healthcare access, especially in vulnerable and underserved populations.
